2007
DOI: 10.1007/s00535-007-2127-8
|View full text |Cite
|
Sign up to set email alerts
|

Current status and future clinical applications of lymphatic mapping in gastrointestinal cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2011
2011
2012
2012

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 29 publications
0
2
0
Order By: Relevance
“…To overcome these problems, the CEUS-guided method of SLN detection has recently been developed. Early gastric cancer is the most suitable target of SLN mapping in gastrointestinal cancer because individualized and minimally invasive surgery based on SLN biopsy might be applicable, (19)(20)(21) However, in cases of gastric cancer, 5-10% of SLN are located in the second compartment that might be accounted for by aberrant drainage routes from the primary lesion. No suitable technique for identify lymphatic networks and SLN located in the second compartment is available.…”
Section: Discussionmentioning
confidence: 99%
“…To overcome these problems, the CEUS-guided method of SLN detection has recently been developed. Early gastric cancer is the most suitable target of SLN mapping in gastrointestinal cancer because individualized and minimally invasive surgery based on SLN biopsy might be applicable, (19)(20)(21) However, in cases of gastric cancer, 5-10% of SLN are located in the second compartment that might be accounted for by aberrant drainage routes from the primary lesion. No suitable technique for identify lymphatic networks and SLN located in the second compartment is available.…”
Section: Discussionmentioning
confidence: 99%
“…Although, SLN navigation surgery for gastric cancer can substantially improve a patient's quality of life [8][9][10][11], SLN mapping and biopsy in cases of gastric cancer have not been accepted as standard treatment because of their drawbacks in technical aspects and a lack of positive, long-term oncological outcomes, unlike for breast cancer or malignant melanoma. Furthermore, the multidirectional lymphatic pathway of the stomach, procedural complexity of SLN detection, and difficulties in applying laparoscopic procedures result in the slower-than-expected clinical application of SLN mapping and biopsy in cases of gastric cancer surgery [12,13].…”
mentioning
confidence: 99%